Dear Subscriber, |
Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Alcohol / Addiction / Illegal Drugs News | |
Holding Alcohol Retailers Liable Reduces Alcohol-Related Problems Says US Task Force Holding retailers that sell alcohol liable for damage caused by customers under the influence of alcohol bought on their premises can reduce alcohol-related problems, including deaths on the road, injuries and homicides, says the Community Preventive Services Task Force, an independent body whose members, all volunteer experts working in public health and prevention, are appointed by the US Centers for Disease Control and Prevention (CDC). | 12 Aug 2011 |
Tanning Bed Users Exhibit Brain Changes And Behavior Similar To Addicts, UT Southwestern Researchers Find People who frequently use tanning beds may be spurred by an addictive neurological reward-and-reinforcement trigger, researchers at UT Southwestern Medical Center have found in a pilot study. | 12 Aug 2011 |
Alzheimer's / Dementia News | |
Global Standardization For Alzheimer's Biomarkers Moves A Major Step Closer To Reality Citeline, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials recently reviewed the findings from the 14th International Conference on Alzheimer's Disease (ICAD 2011/AAIC 2011) July 16-21, 2011, noting that while pharma continues to develop beta amyloid targeting drugs, amyloid targets are moving ahead in terms of biomarkers and early warning for risk of Alzheimer's. | 12 Aug 2011 |
Arthritis / Rheumatology News | |
Glenmark Initiates Phase IIb Human Trials Globally For Its Novel Molecule 'Revamilast' Glenmark Pharmaceuticals announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases. | 12 Aug 2011 |
Arthritis Sufferers Are Not Engaging In Physical Activity Critical To Their Health Being physically active is one of best ways people with arthritis can improve their health, but a new study from Northwestern University Feinberg School of Medicine shows that more than half of women and 40 percent of men with arthritis are virtually couch potatoes. | 12 Aug 2011 |
Wayne State Researcher Discovers Antibiotic Useful For Localized Treatment Of Bone Wear Total joint replacement surgeries can help relieve joint pain common in people with conditions like osteoarthritis. But sometimes, the debris from prosthetic joints leads to aseptic loosening, or disintegration of surrounding bones. | 12 Aug 2011 |
Heart Disease News | |
Women Who Smoke 25% More Likely To Develop Coronary Heart Disease Than Male Smokers Published Online first by The Lancet , a new study has revealed that women have a 25% higher increased risk of developing coronary heart disease conferred by smoking in comparison with men. Researchers suggest that cigarette toxins may have a more powerful effect on women and the increased risk may be due to physiological differences between the sexes. | 12 Aug 2011 |
Heart Patients Could Benefit From Different Drug, Study Shows Patients with an irregular heart beat could benefit from a drug that is easier to administer than the current standard treatment.The condition, which is more common with older age and affects about 800,000 people in the UK, can lead to blood clots forming and significantly increases the risk of stroke. | 12 Aug 2011 |
Trastuzumab Raises Risk Of Heart Problems In The Elderly With History Of Heart Disease Or Diabetes The first study to investigate the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients has found that it increases the risk of heart problems, particularly in women with a history of heart disease, diabetes or both. | 12 Aug 2011 |
IT / Internet / E-mail News | |
Could An "Ankle Hotline" Relieve Strain On Healthcare Demands? New study suggests that precious ER resources could be spared by finding alternative ways to assess and treat lower leg injuries.Should lower leg strains and sprains take up valuable ER time and resources? According to a new study by Kaj Lambers and colleagues, from Massachusetts General Hospital in Boston, USA, strains and sprains account for over a third of lower extremity injuries treated at emergency departments. | 12 Aug 2011 |
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
No comments:
Post a Comment
please visit again